
|Articles|October 1, 2018
- Pharmaceutical Executive-10-01-2018
- Volume 38
- Issue 10
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's Emerging Pharma Leaders 2018about 7 years ago
Choosing the Right Track: Pharma & Healthcare MBAsover 7 years ago
Getting Where You Need to Goover 7 years ago
Vienna’s Vision on Health Regulation in Europeover 7 years ago
FDA Launches Major Push for New Antimicrobialsover 7 years ago
Medical Affairs’ Search for MeaningNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
J.P. Morgan 2026: Pfizer’s Pivot from Covid to Pipeline Execution
2
Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
3
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
4




